# Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data

> **NCT04606264** · PHASE3 · COMPLETED · sponsor: **Jennifer Holder-Murray** · enrollment: 2977 (actual)

## Conditions studied

- Perioperative Optimization

## Interventions

- **DRUG:** Neuraxial Analgesia
- **DRUG:** Regional Block 1: Paravertebral
- **DRUG:** Perphenazine
- **DRUG:** Aprepitant
- **DRUG:** Dimenhydrinate
- **DRUG:** Ondansetron 4 MG
- **DRUG:** Dexamethasone
- **DRUG:** Regional Block 2: QL1

## Key facts

- **NCT ID:** NCT04606264
- **Lead sponsor:** Jennifer Holder-Murray
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-15
- **Primary completion:** 2025-03-21
- **Final completion:** 2025-03-21
- **Target enrollment:** 2977 (ACTUAL)
- **Last updated:** 2025-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04606264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04606264, "Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04606264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*